Kaidong Liu

发表

Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma

Ting Chen, Yunyan Gu, Min Zou, 2022, Molecular oncology.

A genetic map of the chromatin regulators to drug response in cancer cells

Ting Chen, Yunyan Gu, Min Zou, 2022, Journal of Translational Medicine.

A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level

Ting Chen, Yunyan Gu, Zhiqiang Chang, 2021, Molecular Therapy. Nucleic Acids.

Discovering a qualitative transcriptional signature of homologous recombination defectiveness for prostate cancer

Xia Li, Yunyan Gu, Min Zou, 2021, iScience.

Synthetic viability induces resistance to immune checkpoint inhibitors in cancer cells

Yunyan Gu, Yang Hui, Zhangxiang Zhao, 2023, British Journal of Cancer.

Mutant RB1 enhances therapeutic efficacy of PARPis in lung adenocarcinoma by triggering the cGAS/STING pathway

Yunyan Gu, Haihai Liang, Tong Yu, 2023, JCI insight.

Harnessing genetic interactions for prediction of immune checkpoint inhibitors response signature in cancer cells.

Yunyan Gu, Zhangxiang Zhao, Kaidong Liu, 2024, Cancer letters.

Individualized detection of TMPRSS2-ERG fusion status in prostate cancer: a rank-based qualitative transcriptome signature

Yunyan Gu, Zhangxiang Zhao, Kaidong Liu, 2024, World journal of surgical oncology.

Up-regulated SPP1 increases the risk from IPF to lung cancer via activating the pro-tumor macrophages

Yunyan Gu, Zhangxiang Zhao, Kaidong Liu, 2023, Computational and structural biotechnology journal.

Single-cell landscape of intratumoral heterogeneity and tumor microenvironment remolding in pre-nodal metastases of breast cancer

Yunyan Gu, Kaidong Liu, Bo Chen, 2024, Journal of translational medicine.